Most of DE genes predicted were conserved across the two different analyses, including the genes IFITM2, SELL, and FAM65B, which were also predicted to be significantly downregulated in LT COVID-19 patients compared with healthy participants. The gene discussed is RIPOR2; the disease is COVID-19.